Affinity Biologicals Inc. is excited to announce that in order improve quantitative thrombosis and hemostasis research they are introducing laboratories to the Factor VII Antigen Elisa Kit, a new addition to the existing Factor VIII Inhibitor Kits.
Ancaster, Canada, May 08, 2015 –(PR.com)– As a vitamin K-dependent glycoprotein, Factor VII is initially produced in the liver and is used to find elevated levels of Factor VII. If this is the case, it could be indicative of Congenital Factor VII deficiency or coronary heart disease.
The contents of this kit include a pre-coated plate, calibrator plasma, sample diluent and wash buffer concentrate, and ready-to-use detecting antibody TMB substrate and stop solutions. Other ELISA kit products from Affinity Biologicals Inc. can be used in the quantification of Factor VI, Factor VII, Factor VII, Factor IX, and Factor XI antigen levels.
It is important to remember that the VisuLize Factor VII Antigen ELISA Kit was designed specifically for research, and not diagnostic purposes. To find out more about any of the Factor VIII inhibitor kits or any of the other products available from Affinity Biologicals Inc. visit their website today at http://www.affinitybiologicals.com/.
About Affinity Biologicals Inc.
Affinity Biologicals is a renowned name associated with the medical research and diagnostics industry since 1987. The company has manufactured over 250 reagents used internationally in the research and diagnostics of hemostasis and thrombosis to date. The product range of Affinity Biologicals include coagulation antibodies, deficient plasmas, antibody sets of ELISA, control plasmas, custom plasmas, and factor inhibitor plasmas.
Affinity Biologicals Inc.
1395 Sandhill Drive, Ancaster, ON, Canada L9G 4V5.